IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
714.10
-3.37 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
710.02
-4.08 (-0.57%)
After-hours: Dec 5, 2025, 5:34 PM EST
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 683.89, with a low estimate of 475 and a high estimate of 830. The average target predicts a decrease of -4.23% from the current stock price of 714.10.
Analyst Consensus: Buy
* Price targets were last updated on Nov 4, 2025.
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $765 → $805 | Buy | Maintains | $765 → $805 | +12.73% | Nov 4, 2025 |
| UBS | UBS | Hold Maintains $710 → $750 | Hold | Maintains | $710 → $750 | +5.03% | Nov 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $675 → $775 | Buy | Maintains | $675 → $775 | +8.53% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Maintains $785 → $830 | Strong Buy | Maintains | $785 → $830 | +16.23% | Nov 4, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $640 → $700 | Hold → Strong Buy | Upgrades | $640 → $700 | -1.97% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
4.37B
from 3.90B
Increased by 12.15%
Revenue Next Year
4.76B
from 4.37B
Increased by 8.79%
EPS This Year
13.15
from 10.67
Increased by 23.29%
EPS Next Year
14.73
from 13.15
Increased by 11.98%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.5B | 5.0B | ||||
| Avg | 4.4B | 4.8B | ||||
| Low | 4.2B | 4.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.7% | 13.3% | ||||
| Avg | 12.1% | 8.8% | ||||
| Low | 7.6% | 3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.65 | 15.72 | ||||
| Avg | 13.15 | 14.73 | ||||
| Low | 12.21 | 13.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 27.9% | 19.5% | ||||
| Avg | 23.3% | 12.0% | ||||
| Low | 14.4% | 5.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.